Posters

Neurogenerative Diseases and Women’s Health in the Rio Grande Valley: A Retrospective Chart Review on Parkinson’s, Alzheimer’s and Multiple Sclerosis

Presenting Author Academic/Professional Position

Erica Burrell-Walker

Academic Level (Author 1)

Medical Student

Academic Level (Author 2)

Medical Student

Academic Level (Author 3)

Medical Student

Academic Level (Author 4)

Medical Student

Academic Level (Author 5)

Medical Student

Discipline Track

Community/Public Health

Abstract Type

Research/Clinical

Abstract

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized primarily by motor symptoms including but not limited to tremors and rigidity. Symptoms of this disorder result from the loss of dopaminergic neurons in the brain. Alzheimer’s disease (AD) is the most common cause of dementia, making up 60-80% of cases. AD is marked my memory loss, cognitive decline and behavioral changes. Hallmarks of this disorder include amyloid-beta plaques and neurofibrillary tangles and neuronal loss. Multiple sclerosis (MS) is chronic autoimmune disease that affects the central nervous system. In this disease, there is immunemediated destruction of the myelin sheath which leads to disrupted communication between the brain and the body. The clinical presentation for MS is highly variable. Previous studies suggest that men are at a greater risk of developing PD than women. Between Hispanic males and females, studies show that Hispanic Americans have a higher chance of developing AD. Women are nearly twice as likely to develop AD. Studies involving MS show that Hispanics overall have a lower risk of developing MS compared to non-Hispanic whites. Though there is lower overall risk, there are unique challenges related to MS faced by the Hispanic community. There is limited research on incidence rates of Parkinson’s disease between Hispanic males and females in the Rio Grande Valley and the factors that may contribute to possible disparities. There is also limited research that focuses specifically on MS. This study aims to investigate the relationship between neurogenerative diseases and how gender and ethnicity plays a key role.

Materials and Methods

  • Conducted a retrospective chart review of UT Health RGV medical records for Parkinson’s, Alzheimer’s disease and multiple sclerosis patients from January 2019.
  • Parkinson’s ICD-10 codes included: G20, G20.0, G20.1. G20.2. G20.3, G20.8. G20.9
  • Found 152 unique patients with a Parkinson’s diagnosis.
  • Alzheimer’s disease ICD-10 included: G30, G30.0., G30.1. G30.8, G30.9
  • Found 75 unique patients with a Alzheimer’s diagnosis.
  • Multiple sclerosis ICD-10 included: G35, G35.0. G35.1, G35.2, G35.3 • Found 52 unique patients with a Multiple sclerosis diagnosis. • Excluded duplicated charts
  • Planned statistical analysis on age, sex, ethnicity and insurance type.

Presentation Type

Poster

This document is currently not available here.

Share

COinS
 

Neurogenerative Diseases and Women’s Health in the Rio Grande Valley: A Retrospective Chart Review on Parkinson’s, Alzheimer’s and Multiple Sclerosis

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized primarily by motor symptoms including but not limited to tremors and rigidity. Symptoms of this disorder result from the loss of dopaminergic neurons in the brain. Alzheimer’s disease (AD) is the most common cause of dementia, making up 60-80% of cases. AD is marked my memory loss, cognitive decline and behavioral changes. Hallmarks of this disorder include amyloid-beta plaques and neurofibrillary tangles and neuronal loss. Multiple sclerosis (MS) is chronic autoimmune disease that affects the central nervous system. In this disease, there is immunemediated destruction of the myelin sheath which leads to disrupted communication between the brain and the body. The clinical presentation for MS is highly variable. Previous studies suggest that men are at a greater risk of developing PD than women. Between Hispanic males and females, studies show that Hispanic Americans have a higher chance of developing AD. Women are nearly twice as likely to develop AD. Studies involving MS show that Hispanics overall have a lower risk of developing MS compared to non-Hispanic whites. Though there is lower overall risk, there are unique challenges related to MS faced by the Hispanic community. There is limited research on incidence rates of Parkinson’s disease between Hispanic males and females in the Rio Grande Valley and the factors that may contribute to possible disparities. There is also limited research that focuses specifically on MS. This study aims to investigate the relationship between neurogenerative diseases and how gender and ethnicity plays a key role.

Materials and Methods

  • Conducted a retrospective chart review of UT Health RGV medical records for Parkinson’s, Alzheimer’s disease and multiple sclerosis patients from January 2019.
  • Parkinson’s ICD-10 codes included: G20, G20.0, G20.1. G20.2. G20.3, G20.8. G20.9
  • Found 152 unique patients with a Parkinson’s diagnosis.
  • Alzheimer’s disease ICD-10 included: G30, G30.0., G30.1. G30.8, G30.9
  • Found 75 unique patients with a Alzheimer’s diagnosis.
  • Multiple sclerosis ICD-10 included: G35, G35.0. G35.1, G35.2, G35.3 • Found 52 unique patients with a Multiple sclerosis diagnosis. • Excluded duplicated charts
  • Planned statistical analysis on age, sex, ethnicity and insurance type.